Related Experiment Video

Updated: Aug 7, 2026

Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
06:31

Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids

Published on: June 2, 2023

[Tryptase activity in colon mucosal samples of children with inflammatory bowel disease]

Stefan Popadiuk1, Joanna Renke, Jolanta Gleń

  • 1Klinika Pediatrii, Gastroenterologii i Onkologii Dzieciecej, Akademia Medyczna, ul. Nowe Ogrody 1-6, 80-803 Gdansk, Poland. step@amg.gda.pl

Medycyna Wieku Rozwojowego
|July 11, 2006
PubMed

Insights

Tryptase activity in colon mucosa was similar in children with inflammatory bowel diseases (IBD) and gastrointestinal bleeding, but significantly higher than in plasma. Mast cell degranulation may vary with IBD type.

Area of Science:

  • Gastroenterology
  • Immunology
  • Pediatrics

Context:

  • Mast cells are prevalent in mucosal tissues, releasing tryptase, a key mediator of inflammation.
  • Tryptase plays a significant role in cellular and tissue responses during inflammatory processes.

Purpose:

  • To compare tryptase activity in colon mucosa of pediatric patients with inflammatory bowel diseases (IBD) and those with lower gastrointestinal bleeding (GTB) without inflammation.
  • To investigate tryptase activity across different IBD subtypes: ulcerative colitis (UC), Crohn's disease (CD), and non-specific colitis (NSC).

Summary:

  • No significant difference in mean tryptase activity was observed between children with IBD and GTB.
  • Tryptase activity in colon mucosa was substantially higher than in plasma (normal range 1-19 ug/l).
  • Kruskal-Wallis analysis revealed statistically significant differences in tryptase activity among IBD subtypes (p=0.034), with non-specific colitis showing a notable elevation.

Impact:

  • Findings suggest that while overall tryptase levels may not differentiate IBD from GTB, variations within IBD subtypes exist.
  • The elevated tryptase in colon mucosa compared to plasma highlights localized mast cell activity.
  • This research may inform diagnostic and therapeutic strategies targeting mast cell mediators in pediatric gastrointestinal disorders.
Abstract

More Related Videos

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

Related Concept Videos

Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...